Cargando…
Inhaled nebulized glatiramer acetate against Gram-negative bacteria is not associated with adverse pulmonary reactions in healthy, young adult female pigs
The developmental speed of new antimicrobials does not meet the emergence of multidrug-resistant bacteria sufficiently. A potential shortcut is assessing the antimicrobial activity of already approved drugs. Intrudingly, the antibacterial action of glatiramer acetate (GA) has recently been discovere...
Autores principales: | Skovdal, Sandra M., Christiansen, Stig Hill, Johansen, Karen Singers, Viborg, Ole, Bruun, Niels Henrik, Jensen-Fangel, Søren, Holm, Ida Elisabeth, Vorup-Jensen, Thomas, Petersen, Eskild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786617/ https://www.ncbi.nlm.nih.gov/pubmed/31600340 http://dx.doi.org/10.1371/journal.pone.0223647 |
Ejemplares similares
-
The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria
por: Christiansen, Stig Hill, et al.
Publicado: (2017) -
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
por: Jalilian, Babak, et al.
Publicado: (2012) -
Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa
por: Murphy, Ronan A., et al.
Publicado: (2022) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018) -
Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)